TB-500 is the active region of thymosin beta-4 (Ac-SDKP sequence context), a peptide involved in actin regulation, cell migration and wound repair. Animal studies show promise for cardiac repair and dermal healing.
Human clinical data is minimal. Commonly discussed in equine medicine contexts, which is where much of the dosing folklore originates.
This entry is informational only.